ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
96
Frequently Asked Questions
What is Market Cap of ProPhase Labs Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ProPhase Labs Inc market cap is $18.01M.
What is the 52-week high for ProPhase Labs Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ProPhase Labs Inc 52 week high is $2.72 as of September 15, 2025.
What is the 52-week low for ProPhase Labs Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ProPhase Labs Inc 52 week low is $0.2179 as of September 15, 2025.
What is ProPhase Labs Inc stock price today?
ProPhase Labs Inc stock price today is $0.4299.
What was ProPhase Labs Inc stock price yesterday?
ProPhase Labs Inc stock price yesterday was $0.4335.
What is the PE ratio of ProPhase Labs Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ProPhase Labs Inc’s P/E ratio is -0.29.
What is the Price-to-Book ratio of ProPhase Labs Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ProPhase Labs Inc P/B ratio is 1.5747.
What is the 50-day moving average of ProPhase Labs Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ProPhase Labs Inc 50-day moving average is $0.3752.
